Concepedia

Guillaume Herbreteau

GH

10

Publications

341

Citations

10

H-Index

2016

Active since

Affiliations

Inserm(Current)

Nantes Université

Centre Hospitalier Universitaire de Nantes

Centre d'Investigation Clinique de Nantes

Centre de Recherche en Cancérologie et Immunologie Intégrée Nantes Angers

Guillaume Herbreteau is an author at Inserm specializing in medicine, pathology, and oncology.

ORCID

Top concepts

Publications per year

2016–2023

10

Publications

10

Treatment of two infants with PIK3CA-related overgrowth spectrum by alpelisib

G Morin, C. Degrugillier-Chopinet, Marie Vincent et al. · The Journal of Experimental Medicine · 2022 · 64 citations · Full text

, , +14

Persistent deficiency of circulating mucosal-associated invariant T (MAIT) cells in ANCA-associated vasculitis

Cécile Braudeau, Karine Amouriaux, A. Néel et al. · Journal of Autoimmunity · 2016 · 60 citations

, , +12

Quantitative monitoring of circulating tumor DNA predicts response of cutaneous metastatic melanoma to anti-PD1 immunotherapy

Guillaume Herbreteau, Audrey Vallée, Anne‐Chantal Knol et al. · Oncotarget · 2018 · 53 citations · Full text

Circulating Tumor DNA as a Prognostic Determinant in Small Cell Lung Cancer Patients Receiving Atezolizumab

Guillaume Herbreteau, Alexandra Langlais, Laurent Greillier et al. · Journal of Clinical Medicine · 2020 · 45 citations · Full text

Clinical significance of <scp>BRAF</scp> mutation status in circulating tumor <scp>DNA</scp> of metastatic melanoma patients at baseline

Anne Chantal Knol, Audrey Vallée, Guillaume Herbreteau et al. · Experimental Dermatology · 2016 · 35 citations

Rows per page

1–5 of 10